Lead Product(s) : Amitriptyline
Therapeutic Area : Rare Diseases and Disorders
Study Phase : Preclinical
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
AlgoTherapeutix Announces Orphan Drug Designation Granted by FDA for ATX01 in Erythromelalgia
Details : U.S. Food and Drug Administration (FDA) has granted ATX01 (proprietary topical amitriptyline) Orphan Drug Designation for the treatment of erythromelalgia. The ATX01 program primarily targets Chemotherapy-Induced Peripheral Neuropathy.
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
August 06, 2020
Lead Product(s) : Amitriptyline
Therapeutic Area : Rare Diseases and Disorders
Highest Development Status : Preclinical
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Amitriptyline
Therapeutic Area : Neurology
Study Phase : Phase III
Sponsor : Cristalia Produtos Quimicos Farma. Ltda
Deal Size : Inapplicable
Deal Type : Inapplicable
Treatment of Neuropathic Pain in Leprosy
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
October 27, 2017
Lead Product(s) : Amitriptyline
Therapeutic Area : Neurology
Highest Development Status : Phase III
Sponsor : Cristalia Produtos Quimicos Farma. Ltda
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Amitriptyline
Therapeutic Area : Neurology
Study Phase : Undisclosed
Sponsor : Migraine Research Foundation
Deal Size : Inapplicable
Deal Type : Inapplicable
Prediction of Migraine Prevention Efficacy Based on Individual's Pain Modulation
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
April 02, 2014
Lead Product(s) : Amitriptyline
Therapeutic Area : Neurology
Highest Development Status : Undisclosed
Sponsor : Migraine Research Foundation
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Amitriptyline
Therapeutic Area : Neurology
Study Phase : Undisclosed
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
July 13, 2010
Lead Product(s) : Amitriptyline
Therapeutic Area : Neurology
Highest Development Status : Undisclosed
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
